应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MNKD 曼恩凯德生物医疗
已收盘 11-04 16:00:00 EST
7.09
-0.08
-1.12%
盘后
7.09
+0.00
0.00%
19:59 EST
最高
7.33
最低
7.06
成交量
227.84万
今开
7.18
昨收
7.17
日振幅
3.77%
总市值
19.50亿
流通市值
19.06亿
总股本
2.75亿
成交额
1,639万
换手率
0.85%
流通股本
2.69亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
曼恩凯德生物医疗盘中异动 快速拉升5.20%报6.88美元
市场透视 · 10-28
曼恩凯德生物医疗盘中异动 快速拉升5.20%报6.88美元
曼恩凯德生物医疗盘中异动 快速拉升5.17%报6.62美元
市场透视 · 10-03
曼恩凯德生物医疗盘中异动 快速拉升5.17%报6.62美元
曼恩凯德生物医疗盘中异动 早盘急速拉升5.06%
自选股智能写手 · 08-19
曼恩凯德生物医疗盘中异动 早盘急速拉升5.06%
曼恩凯德生物医疗2024财年第二财季实现净利润-2.01百万美元,同比增加61.86%
自选股智能写手 · 08-17
曼恩凯德生物医疗2024财年第二财季实现净利润-2.01百万美元,同比增加61.86%
MannKind Corp 预计每股收益1美分 - 财报前瞻
Reuters · 08-05
MannKind Corp 预计每股收益1美分 - 财报前瞻
曼恩凯德生物医疗盘中异动 股价大跌6.37%报5.00美元
自选股智能写手 · 08-05
曼恩凯德生物医疗盘中异动 股价大跌6.37%报5.00美元
曼恩凯德生物医疗盘中异动 急速上涨5.07%
自选股智能写手 · 07-09
曼恩凯德生物医疗盘中异动 急速上涨5.07%
曼恩凯德生物医疗盘中异动 快速拉升5.19%报5.38美元
自选股智能写手 · 06-25
曼恩凯德生物医疗盘中异动 快速拉升5.19%报5.38美元
曼恩凯德生物医疗盘中异动 股价大跌5.06%报4.79美元
自选股智能写手 · 06-15
曼恩凯德生物医疗盘中异动 股价大跌5.06%报4.79美元
曼恩凯德生物医疗盘中异动 下午盘大幅上涨5.18%报4.98美元
自选股智能写手 · 06-14
曼恩凯德生物医疗盘中异动 下午盘大幅上涨5.18%报4.98美元
曼恩凯德生物医疗盘中异动 早盘股价大跌5.14%报4.43美元
自选股智能写手 · 06-10
曼恩凯德生物医疗盘中异动 早盘股价大跌5.14%报4.43美元
曼恩凯德生物医疗2024财年第一财季实现净利润10.63百万美元,同比增加208.47%
自选股智能写手 · 05-17
曼恩凯德生物医疗2024财年第一财季实现净利润10.63百万美元,同比增加208.47%
曼恩凯德生物医疗盘中异动 早盘快速下挫5.00%报4.18美元
自选股智能写手 · 05-09
曼恩凯德生物医疗盘中异动 早盘快速下挫5.00%报4.18美元
加载更多
公司概况
公司名称:
曼恩凯德生物医疗
所属市场:
NASDAQ
上市日期:
--
主营业务:
Mannkind Corporation于1991年2月14日在美国特拉华州注册成立。Mannkind Corporation是一家生物制药公司,侧重于诸如糖尿病和癌症之类疗法和药品的开发、研制和推广。该公司的主导候选产品——AFREZZA吸入粉末,是一种超速效胰岛素,处于后期临床研究阶段,用于成人1型或2型糖尿病高血糖的控制治疗。AFREZZA是由该公司的专有技术圈颗粒加载到胰岛素分子里。这些加载的粒子雾化吸入后,会深入到使用AFREZZA吸入器的肺部。糖尿病是一个重大的健康问题。
发行价格:
--
{"stockData":{"symbol":"MNKD","market":"US","secType":"STK","nameCN":"曼恩凯德生物医疗","latestPrice":7.09,"timestamp":1730754000000,"preClose":7.17,"halted":0,"volume":2278427,"hourTrading":{"tag":"盘后","latestPrice":7.09,"preClose":7.09,"latestTime":"19:59 EST","volume":40405,"amount":286693.0375,"timestamp":1730768351728},"delay":0,"floatShares":268879862,"shares":274995037,"eps":0.043399,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.08,"latestTime":"11-04 16:00:00 EST","open":7.18,"high":7.325,"low":7.055,"amount":16393813.8220191,"amplitude":0.037657,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.043399,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1730797200000},"adr":0,"listingDate":1090987200000,"adjPreClose":7.17,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":7.1642,"preClose":7.17,"latestTime":"09:29 EST","volume":7545,"amount":54839.931627000005,"timestamp":1730730596708},"postHourTrading":{"tag":"盘后","latestPrice":7.09,"preClose":7.09,"latestTime":"19:59 EST","volume":40405,"amount":286693.0375,"timestamp":1730768351728},"volumeRatio":0.65756,"impliedVol":0.4204,"impliedVolPercentile":0.49},"requestUrl":"/m/hq/s/MNKD","defaultTab":"news","newsList":[{"id":"2478148734","title":"曼恩凯德生物医疗盘中异动 快速拉升5.20%报6.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478148734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478148734?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:44","pubTimestamp":1730126676,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时44分,曼恩凯德生物医疗股票出现异动,股价急速拉升5.20%。截至发稿,该股报6.88美元/股,成交量50.734万股,换手率0.18%,振幅4.20%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为0.58%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224437ab7becba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028224437ab7becba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2472673611","title":"曼恩凯德生物医疗盘中异动 快速拉升5.17%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472673611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472673611?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:07","pubTimestamp":1727964437,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时07分,曼恩凯德生物医疗股票出现波动,股价大幅上涨5.17%。截至发稿,该股报6.62美元/股,成交量69.1327万股,换手率0.25%,振幅5.41%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.63%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003220717ab6799a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003220717ab6799a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2460703209","title":"曼恩凯德生物医疗盘中异动 早盘急速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460703209","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460703209?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:57","pubTimestamp":1724075820,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时57分,曼恩凯德生物医疗股票出现波动,股价快速上涨5.06%。截至发稿,该股报5.40美元/股,成交量44.2137万股,换手率0.16%,振幅4.14%。机构评级方面,在所有4家参与评级的机构中,75%的券商给予买入建议,25%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为1.00%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192157019719924e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408192157019719924e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2460492652","title":"曼恩凯德生物医疗2024财年第二财季实现净利润-2.01百万美元,同比增加61.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460492652","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460492652?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824030,"startTime":"0","endTime":"0","summary":"8月17日,曼恩凯德生物医疗公布财报,公告显示公司2024财年第二财季净利润为-2.01百万美元,同比增加61.86%;其中营业收入为72.39百万美元,同比增加48.92%,每股基本收益为-0.01美元。从资产负债表来看,曼恩凯德生物医疗总负债6.70亿美元,其中短期债务13.10百万美元,资产负债比为0.67,流动比率为0.05。机构评级:截至2024年8月17日,当前有5家机构对曼恩凯德生物医疗目标价做出预测,其中目标均价为7.30美元,其中最低目标价为5.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004429f31afb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170004429f31afb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD"],"gpt_icon":0},{"id":"2457770338","title":"MannKind Corp 预计每股收益1美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457770338","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457770338?lang=zh_cn&edition=full","pubTime":"2024-08-05 23:55","pubTimestamp":1722873323,"startTime":"0","endTime":"0","summary":" * MannKind公司 将于8月7日公布截至2024年6月30日的财报,预计该公司的季度收入将有所增长。* 根据LSEG的数据,4位分析师的平均预期显示,这家总部位于康涅狄格州丹伯里的公司的营收预计将从去年同期的4861万美元增长33.3%,达到6481.3万美元。* LSEG 分析师对 MannKind 公司的平均预期为每股收益 1 美分。* 华尔街对 MannKind 公司 12 个月目标价的中位数为 6.50 美元,高于其上次收盘价 5.34 美元。8月5日 - 以前季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"MannKind Corp 预计每股收益1美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD"],"gpt_icon":0},{"id":"2457754817","title":"曼恩凯德生物医疗盘中异动 股价大跌6.37%报5.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457754817","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457754817?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:35","pubTimestamp":1722864958,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时35分,曼恩凯德生物医疗股票出现波动,股价急速跳水6.37%。截至发稿,该股报5.00美元/股,成交量18.8727万股,换手率0.07%,振幅1.50%。最近的财报数据显示,该股实现营业收入66.26百万美元,净利润10.63百万美元,每股收益0.04美元,毛利47.67百万美元,市盈率125.00倍。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为1.75%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052135589f107166&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052135589f107166&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MNKD","BK4584"],"gpt_icon":0},{"id":"2450836360","title":"曼恩凯德生物医疗盘中异动 急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450836360","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450836360?lang=zh_cn&edition=full","pubTime":"2024-07-09 00:49","pubTimestamp":1720457342,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日00时49分,曼恩凯德生物医疗股票出现波动,股价急速上涨5.07%。截至发稿,该股报5.39美元/股,成交量91.9796万股,换手率0.34%,振幅4.48%。机构评级方面,在所有5家参与评级的机构中,80%的券商给予买入建议,20%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为0.90%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709004902af911af4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709004902af911af4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2446529004","title":"曼恩凯德生物医疗盘中异动 快速拉升5.19%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446529004","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446529004?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:43","pubTimestamp":1719247401,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日00时43分,曼恩凯德生物医疗股票出现波动,股价大幅上涨5.19%。截至发稿,该股报5.38美元/股,成交量186.988万股,换手率0.69%,振幅5.17%。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为1.89%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004321968164b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625004321968164b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2443670005","title":"曼恩凯德生物医疗盘中异动 股价大跌5.06%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443670005","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443670005?lang=zh_cn&edition=full","pubTime":"2024-06-15 00:33","pubTimestamp":1718382828,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日00时33分,曼恩凯德生物医疗股票出现波动,股价快速下跌5.06%。截至发稿,该股报4.79美元/股,成交量90.532万股,换手率0.33%,振幅4.17%。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.01%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。消息层面,截至00时33分,《Rodman & Renshaw首予曼恩凯德生物医疗买入评级,目标价8美元》资讯为影响曼恩凯德生物医疗的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615003349968145a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615003349968145a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0},{"id":"2443639506","title":"曼恩凯德生物医疗盘中异动 下午盘大幅上涨5.18%报4.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443639506","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2443639506?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:11","pubTimestamp":1718298669,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时11分,曼恩凯德生物医疗股票出现异动,股价快速拉升5.18%。截至发稿,该股报4.98美元/股,成交量105.602万股,换手率0.39%,振幅5.07%。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.07%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。消息层面,截至01时11分,《Rodman & Renshaw首予曼恩凯德生物医疗买入评级,目标价8美元》资讯为影响曼恩凯德生物医疗的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614011109968140f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614011109968140f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD","BK4584","BK4139"],"gpt_icon":0},{"id":"2442847657","title":"曼恩凯德生物医疗盘中异动 早盘股价大跌5.14%报4.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442847657","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442847657?lang=zh_cn&edition=full","pubTime":"2024-06-10 21:48","pubTimestamp":1718027313,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日21时48分,曼恩凯德生物医疗股票出现波动,股价快速下跌5.14%。截至发稿,该股报4.43美元/股,成交量35.9463万股,换手率0.13%,振幅3.21%。最近的财报数据显示,该股实现营业收入66.26百万美元,净利润10.63百万美元,每股收益0.04美元,毛利47.67百万美元,市盈率111.38倍。曼恩凯德生物医疗股票所在的生物技术行业中,整体跌幅为0.48%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214834aef42baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610214834aef42baf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4584","MNKD"],"gpt_icon":0},{"id":"2436602047","title":"曼恩凯德生物医疗2024财年第一财季实现净利润10.63百万美元,同比增加208.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436602047","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436602047?lang=zh_cn&edition=full","pubTime":"2024-05-17 00:24","pubTimestamp":1715876660,"startTime":"0","endTime":"0","summary":"3月31日,曼恩凯德生物医疗公布财报,公告显示公司2024财年第一财季净利润为10.63百万美元,同比增加208.47%;其中营业收入为66.26百万美元,同比增加63.08%,每股基本收益为0.04美元。从资产负债表来看,曼恩凯德生物医疗总负债7.11亿美元,其中短期债务32.24百万美元,资产负债比为0.68,流动比率为0.04。机构评级:截至2024年3月31日,当前有5家机构对曼恩凯德生物医疗目标价做出预测,其中目标均价为7.00美元,其中最低目标价为5.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051700242287713ae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051700242287713ae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MNKD"],"gpt_icon":0},{"id":"2434013000","title":"曼恩凯德生物医疗盘中异动 早盘快速下挫5.00%报4.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434013000","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434013000?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:47","pubTimestamp":1715262453,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时47分,曼恩凯德生物医疗股票出现异动,股价大幅跳水5.00%。截至发稿,该股报4.18美元/股,成交量30.0423万股,换手率0.11%,振幅8.18%。机构评级方面,在所有5家参与评级的机构中,80%的券商给予买入建议,20%的券商给予持有建议,无券商给予卖出建议。曼恩凯德生物医疗股票所在的生物技术行业中,整体涨幅为0.14%。曼恩凯德生物医疗公司简介:MannKind Corp是一家生物制药公司。该产品由小型便携式吸入器提供的人胰岛素干粉制剂组成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921473387e86ca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050921473387e86ca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4584","MNKD","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mannkindcorp.com","stockEarnings":[{"period":"1week","weight":0.0963},{"period":"1month","weight":0.1399},{"period":"3month","weight":0.3427},{"period":"6month","weight":0.6333},{"period":"1year","weight":0.8015},{"period":"ytd","weight":0.9698}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mannkind Corporation于1991年2月14日在美国特拉华州注册成立。Mannkind Corporation是一家生物制药公司,侧重于诸如糖尿病和癌症之类疗法和药品的开发、研制和推广。该公司的主导候选产品——AFREZZA吸入粉末,是一种超速效胰岛素,处于后期临床研究阶段,用于成人1型或2型糖尿病高血糖的控制治疗。AFREZZA是由该公司的专有技术圈颗粒加载到胰岛素分子里。这些加载的粒子雾化吸入后,会深入到使用AFREZZA吸入器的肺部。糖尿病是一个重大的健康问题。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.045334},{"month":2,"riseRate":0.4,"avgChangeRate":-0.004536},{"month":3,"riseRate":0.45,"avgChangeRate":-0.008047},{"month":4,"riseRate":0.4,"avgChangeRate":-0.028112},{"month":5,"riseRate":0.55,"avgChangeRate":0.120551},{"month":6,"riseRate":0.55,"avgChangeRate":0.062891},{"month":7,"riseRate":0.3,"avgChangeRate":-0.060302},{"month":8,"riseRate":0.428571,"avgChangeRate":0.006818},{"month":9,"riseRate":0.666667,"avgChangeRate":0.074573},{"month":10,"riseRate":0.47619,"avgChangeRate":-0.038748},{"month":11,"riseRate":0.47619,"avgChangeRate":0.025398},{"month":12,"riseRate":0.55,"avgChangeRate":-0.01539}],"exchange":"NASDAQ","name":"曼恩凯德生物医疗","nameEN":"MannKind"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供曼恩凯德生物医疗(MNKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"曼恩凯德生物医疗,MNKD,曼恩凯德生物医疗股票,曼恩凯德生物医疗股票老虎,曼恩凯德生物医疗股票老虎国际,曼恩凯德生物医疗行情,曼恩凯德生物医疗股票行情,曼恩凯德生物医疗股价,曼恩凯德生物医疗股市,曼恩凯德生物医疗股票价格,曼恩凯德生物医疗股票交易,曼恩凯德生物医疗股票购买,曼恩凯德生物医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"曼恩凯德生物医疗(MNKD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供曼恩凯德生物医疗(MNKD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}